Global CDMO Biofarma Group operates as a global contract development and manufacturing organization for food supplements, medical devices, probiotic-based drugs and cosmetics, presenting opportunities to partner on development, scale-up, and international distribution for third-party brands.

Expansion Footprint With multiple production sites across Italy, France, the USA and China, there are nearshore and offshore manufacturing capabilities for European and North American clients, enabling regional supply chain diversification and faster market access.

Diversified Portfolio A broad catalogue of ready-to-distribute products, some with clinical studies, plus out-licensed medical devices and patented dossiers, creates upsell and cross-sell opportunities across nutraceuticals, cosmeceuticals and healthcare devices.

Acquisition Momentum Recent acquisitions of Nutraskills and US Pharma Lab, along with a major private equity exit, signal a growth trajectory and potential for expanded client onboarding, joint ventures, or platform-based partnerships.

Data-Driven Ops Adoption of digital and analytics tools (Power BI, Google Tag Manager, ADP HRMS) suggests openness to process optimization, quality transparency, and collaborative sales intelligence to tailor proposals and improve time-to-market.